MODULATION OF TISSUE INFLAMMATION BY RP105/TLR4
RP105/TLR4 对组织炎症的调节
基本信息
- 批准号:7650337
- 负责人:
- 金额:$ 8.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAntibodiesArthritisAutoimmune DiseasesAutoimmune ProcessB Cell ProliferationB-LymphocytesBindingCellsComplexDendritic CellsDependenceDoseEndotoxinsFailureFibronectinsGeneticGoalsHandHeparitin SulfateHomologous GeneHyaluronanImmune responseInfectionInfection ControlInflammationInflammatoryInflammatory ResponseInjuryLeadLeishmaniaLigandsLightLiteratureLocalizedLymphocyte Antigen 96MediatingMicrobeMolecularMolecular ProfilingMusMyeloid CellsNatural ImmunityOrganPathologyPatternPhysiologicalPlayProcessReagentReceptor SignalingRenaissanceResearchRoleSepsisSignal PathwaySignal TransductionSpecificitySplenomegalySterilityStructureSurfaceTLR4 geneTissuesToll-Like Receptor PathwayToll-like receptorsTurpentineautoimmune arthritisin vivoin vivo Modelinhibitor/antagonistmacrophagemicrobialmouse modelnovelpathogenprogramsresponsesuccess
项目摘要
Activation of Toll-like receptor (TLR signaling) by conserved microbial molecular signatures promotes the
induction of both innate and adaptive immune responses. Such responses need to be kept under tight
control. Immune responses that are delayed or of insufficient vigor can lead to a failure to control infection.
On the other hand, excessive or inappropriate inflammation can be harmful or even fatal. The hyperinflammatory
responses that characterize sepsis provide a paradigmatic example, as do the more localized
inappropriate inflammatory processes associated with arthritis. In addition to signaling the presence of
microbial products, the TLR pathway is also involved in signaling the presence of altered or damaged self.
A variety of molecular patterns generated during tissue inflammation have been shown to signal through
TLR4, the most robustly signaling of the TLRs.
We recently discovered a novel endogenous inhibitor of TLR4 signaling in myeloid cells: the TLR4
homolog RP105. The central hypothesis underlying these studies is that RP105 acts to mute injurious
tissue inflammatory responses through modulation of TLR4 signaling driven by endogenous ligands
unmasked by tissue injury. The long-term goal of this research program is to define the molecular
mechanisms that underlie dysregulation of tissue inflammatory responses in organ-specific autoimmune
diseases such as the autoimmune arthritides. The studies in this proposal will employ genetic approaches
to define the role of RP105 (and TLR4) in two well-defined mouse models of microbial productindependent,
localized, inflammatory tissue injury: (1) sterile inflammation induced by oil of turpentine; and
(2) antibody-induced arthritis.
Toll样受体(TLR信号传导)通过保守的微生物分子标记的激活促进了
诱导先天性和适应性免疫应答。这种反应需要严格控制
控制免疫反应延迟或活力不足可能导致无法控制感染。
另一方面,过度或不适当的炎症可能是有害的,甚至是致命的。高炎症
脓毒症的特征性反应提供了一个典型的例子,
与关节炎相关的不适当的炎症过程。除了发出信号表明存在
除了微生物产物外,TLR途径还参与了改变或受损自身的信号传导。
在组织炎症过程中产生的各种分子模式已被证明可以通过
TLR 4是TLR中信号传导最强的。
我们最近在骨髓细胞中发现了一种新的内源性TLR 4信号抑制剂:
同源物RP 105。这些研究的核心假设是RP 105可以抑制有害的
通过内源性配体驱动的TLR 4信号转导调节的组织炎症反应
被组织损伤所掩盖这项研究计划的长期目标是确定
器官特异性自身免疫性疾病中组织炎症反应失调的机制
自身免疫性关节炎等疾病。本提案中的研究将采用遗传学方法
为了确定RP 105(和TLR 4)在两种明确的微生物产物独立小鼠模型中的作用,
局部炎性组织损伤:(1)由松节油诱导的无菌性炎症;
(2)抗体诱发的关节炎
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher L Karp其他文献
Getting to the core of the gut microbiome
触及肠道微生物组的核心
- DOI:
10.1038/nbt0409-344 - 发表时间:
2009-04-01 - 期刊:
- 影响因子:41.700
- 作者:
Matthias H Tschöp;Philip Hugenholtz;Christopher L Karp - 通讯作者:
Christopher L Karp
Christopher L Karp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher L Karp', 18)}}的其他基金
Allergenicity resulting from functional mimicry of the TLR complex
TLR 复合体的功能模仿导致过敏性
- 批准号:
7867274 - 财政年份:2010
- 资助金额:
$ 8.78万 - 项目类别:
MODULATION OF TISSUE INFLAMMATION BY RP105/TLR4
RP105/TLR4 对组织炎症的调节
- 批准号:
8098915 - 财政年份:2010
- 资助金额:
$ 8.78万 - 项目类别:
Allergenicity resulting from functional mimicry of the TLR complex
TLR 复合体的功能模仿导致过敏性
- 批准号:
8034306 - 财政年份:2010
- 资助金额:
$ 8.78万 - 项目类别:
Immunobiology of IFRD1, a gene modifying CF lung disease
IFRD1(一种改变 CF 肺病的基因)的免疫生物学
- 批准号:
7904958 - 财政年份:2009
- 资助金额:
$ 8.78万 - 项目类别:
Immunobiology of IFRD1, a gene modifying CF lung disease
IFRD1(一种改变 CF 肺病的基因)的免疫生物学
- 批准号:
7741410 - 财政年份:2009
- 资助金额:
$ 8.78万 - 项目类别:
Regulation of TLR Signaling and Innate Immunity by RP105
RP105 对 TLR 信号传导和先天免疫的调节
- 批准号:
7650111 - 财政年份:2007
- 资助金额:
$ 8.78万 - 项目类别:
Regulation of TLR Signaling and Innate Immunity by RP105
RP105 对 TLR 信号传导和先天免疫的调节
- 批准号:
7455004 - 财政年份:2007
- 资助金额:
$ 8.78万 - 项目类别:
Regulation of TLR Signaling and Innate Immunity by RP105
RP105 对 TLR 信号传导和先天免疫的调节
- 批准号:
7897636 - 财政年份:2007
- 资助金额:
$ 8.78万 - 项目类别:
MODULATION OF TISSUE INFLAMMATION BY RP105/TLR4
RP105/TLR4 对组织炎症的调节
- 批准号:
7475899 - 财政年份:2007
- 资助金额:
$ 8.78万 - 项目类别:
Regulation of TLR Signaling and Innate Immunity by RP105
RP105 对 TLR 信号传导和先天免疫的调节
- 批准号:
7302729 - 财政年份:2007
- 资助金额:
$ 8.78万 - 项目类别:
相似海外基金
Molecular, Functional and Structural Analyses of Anti-PAD Antibodies in Rheumatoid Arthritis
类风湿关节炎抗 PAD 抗体的分子、功能和结构分析
- 批准号:
9893071 - 财政年份:2019
- 资助金额:
$ 8.78万 - 项目类别:
Search for specific antibodies of anti-CCP antibody-negative rheumatoid arthritis -focusing on anti-carbamylated protein antibody-
寻找抗CCP抗体阴性类风湿性关节炎的特异性抗体-聚焦抗氨甲酰化蛋白抗体-
- 批准号:
26460649 - 财政年份:2014
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Measurement of the plasma and synovia levels of citrullinated fibrinogen and antibodies against it in rheumatoid arthritis patients
类风湿性关节炎患者血浆和滑液中瓜氨酸纤维蛋白原及其抗体水平的测量
- 批准号:
25460678 - 财政年份:2013
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A protein array platform for anti-citrulline antibodies in Rheumatoid Arthritis
类风湿性关节炎抗瓜氨酸抗体的蛋白质阵列平台
- 批准号:
8385414 - 财政年份:2012
- 资助金额:
$ 8.78万 - 项目类别:
A protein array platform for anti-citrulline antibodies in Rheumatoid Arthritis
类风湿性关节炎抗瓜氨酸抗体的蛋白质阵列平台
- 批准号:
8549105 - 财政年份:2012
- 资助金额:
$ 8.78万 - 项目类别:
Pathogenicity of Anti-Citrullinated Protein/Peptide Antibodies (ACPA) from Healthy Siblings of Rheumatoid Arthritis (RA) Patients
类风湿关节炎 (RA) 患者健康兄弟姐妹的抗瓜氨酸蛋白/肽抗体 (ACPA) 的致病性
- 批准号:
226436 - 财政年份:2011
- 资助金额:
$ 8.78万 - 项目类别:
Studentship Programs
A role of Fc receptor beta-chain in the onset of arthritis elicited by anti-type II collagen antibodies
Fc 受体 β 链在抗 II 型胶原抗体引发的关节炎发病中的作用
- 批准号:
23791124 - 财政年份:2011
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Identification of new autoantibodies in anti-cyclic citrullinated peptide (CCP) antibodies negative rheumatoid arthritis
抗环瓜氨酸肽(CCP)抗体阴性类风湿性关节炎中新自身抗体的鉴定
- 批准号:
23791112 - 财政年份:2011
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Early therapeutic approaches for Rheumatoid Arthritis by anti-PAD4 antibodies
抗 PAD4 抗体治疗类风湿关节炎的早期方法
- 批准号:
23591444 - 财政年份:2011
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identifying antigens against antibodies produced in lesional synovium of rheumatoid arthritis and application of the enzyme-labeled antigen method
类风湿性关节炎病灶滑膜产生的抗体抗原的鉴定及酶标抗原法的应用
- 批准号:
21890277 - 财政年份:2009
- 资助金额:
$ 8.78万 - 项目类别:
Grant-in-Aid for Research Activity Start-up